Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L7a pseudogene 28 (RPL7AP28) is a nonprotein-coding processed pseudogene found on chromosome 6q21 in the human genome[4]. It is derived from the mRNA of the functional ribosomal protein L7a gene (RPL7A), but because it has no exons and does not encode a protein, it is classified as a pseudogene[4][6][8]. Processed pseudogenes such as RPL7AP28 are generally considered genomic "fossils" created by retrotransposition events; they are widely distributed in the genome due to the essential nature and abundance of ribosomal protein genes[12]. While some pseudogenes have regulatory roles, there is no evidence that RPL7AP28 affects human biology or disease[1][4][6][8]. Key points: - This is a nonfunctional, noncoding pseudogene and not a receptor, protein, or therapeutic target. - Only the parent gene (RPL7A) encodes a functional ribosomal protein, important for protein synthesis[3][7]. - If you require information about the ribosomal protein L7a, refer specifically to the RPL7A gene/protein. Summary: RPL7AP28 is a processed pseudogene with no protein product or therapeutic relevance; it serves no recognized biological or disease role and has no interacting drugs or known biomarkers[1][4][6][8]. If you are searching for a valid therapeutic target, information should be redirected to the parent gene/protein, ribosomal protein L7a (RPL7A)[3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L7a pseudogene 28 (RPL7AP28).